Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Lot-to-Lot Consistency Study of the Investigational, Inactivated, Split-Virion Influenza Vaccine in Adults

This study has been completed.
Information provided by (Responsible Party):
Sanofi ( Sanofi Pasteur, a Sanofi Company ) Identifier:
First received: September 29, 2006
Last updated: January 10, 2014
Last verified: January 2014